- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01985139
Pleasure for Food and Endocannabinoids in Obesity (PLOBEC)
A New Method for the Characterisation of Pleasure for Food in Obesity and Relationships With the Endocannabinoid System
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Disturbances in hedonic and motivational processes play a major role in the pathophysiology of reward-related diseases, such as obesity. To date, experimental approaches for the study of emotional and motivational processing rely on subjective assessment scales. We have therefore developed and validated a novel computer-generated test challenging visual and temporal discrimination capacities in humans. The subjects are asked to view and to compare two stimuli, an appetitive one (food pictures; F) and its devalued counterpart (food pictures in greyscale; D), at each trial, assessing either the size (task A) or the duration of presentation (task B). Geometric figures are used as controls and presented in color (C) or greyscale (D). Both tasks are registered under the French agency for the protection of computer software. Here, we propose to use our novel test to: i) assess the hedonic and motivational state in subjects suffering from obesity, ii) compare their responses with healthy volunteers, and iii) establish relationships with biological markers known to be highly involved in the regulation of both emotional and motivational processes, such as endocannabinoids. Responses to the test in obese patients will be evaluated during two separate experimental sessions under either fasting or satiety conditions.
The present study is expected to begin mid-November 2013 for a total duration of 24 consecutive months. A sample of 25 patients suffering from obesity will be recruited and compared with 25 healthy normal volunteers who are free from any previous or current metabolic and psychiatric disorders. They will be matched on age and sex. They will be screened using the "Association pour la Méthodologie et la Documentation en Psychiatrie" questionnaire for obtaining a series of information, comprising the marital status, number of children, number of siblings, education and training, professional qualifications, significant life events… They will be evaluated with the Mini-International Neuropsychiatric Interview in order to determine the presence of mood disorders and associated psychopathology. The Three-Factor Eating Questionnaire will be employed for measuring three separate aspects of eating behavior: cognitive restraint, uncontrolled eating, and emotional eating. This will be completed with the Multidimensional Body Self-Relations Questionnaire and the State-Trait Anxiety Inventory in order to assess the body satisfaction and anxiety levels, respectively. Beyond all these assessments, two separate experimental sessions will be conducted, one in satiety and the other in fasting. During each session, the participants will be asked to perform the two validated instrumental tasks in front the screen of a computer. Plasma levels of endocannabinoids will be monitered by collecting blood samples prior to the consumption of a calorically-defined meal and while carrying out the computer-generated tasks under satiety. Blood will be withdrawn at the same time-points during the session in fasting. Visual analogue scales (VAS) assessing hunger levels will be completed before blood is collected. A VAS will be also used for the global assessment of appetitive properties of the viewed food images just before the end of the second experimental session.
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Bruno Aouizerate, Professor
- Número de teléfono: +33 05 57 57 37 06
- Correo electrónico: bruno.aouizerate@u-bordeaux2.fr
Ubicaciones de estudio
-
-
-
Bordeaux, Francia, 33077
- Reclutamiento
- Neurocentre Magendie (INSERM U862)
-
Contacto:
- Bruno Aouizerate, Professor
- Número de teléfono: +33 05 57 57 37 06
- Correo electrónico: bruno.aouizerate@u-bordeaux2.fr
-
Investigador principal:
- Bruno Aouizerate, Professor
-
Sub-Investigador:
- Antoine Tabarin, Professor
-
Sub-Investigador:
- Blandine Gatta-Cherifi, Professor
-
Sub-Investigador:
- Camille Gouzien, Doctor
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
Obese patients :
- Be between 18 and 60 year-old
- Have a body mass index ranging from 35 to 50 kg/m2
- Have no previous history of surgical treatment of obesity
- Have received no standard intervention for obesity within the last 3 months before study
- Have a stable weight (variation <5%) within the last 3 months before study
- Have a restriction score <9 on the three-factor eating questionnaire
- Be free from any current and previous psychiatric disorder, such as major depression or drug abuse/dependence
- Understand and accept the design and constraints of the present study
- Be a beneficiary or member of health insurance plan
- Provide written consent to the study after receiving clear information
Healthy volunteers :
- Be between 18 and 60 year-old
- Be free from any current and previous psychiatric disorder, such as major depression or drug abuse/dependence
- Understand and accept the design and constraints of the present study
- Be a beneficiary or member of health insurance plan
- Provide written consent to the study after receiving clear information
Exclusion Criteria:
Obese patients :
- Suffer from monogenic obesity
- Take any psychotropic treatment such as anxiolytic/hypnotic drugs over the last week preceding the study
- Be a pregnant or nursing woman
- Use alcohol over the last two days preceding the study
Healthy volunteers :
- Suffer from any current and previous somatic or psychiatric condition
- Have a body mass index below 18,5 kg/m2 or above 25 kg/m2
- Take any psychotropic treatment such as anxiolytic/hypnotic drugs over the last week preceding the study
- Be a pregnant or nursing woman
- Use alcohol over the last two days preceding the study
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Poner en pantalla
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Obese patients
Computer-based tasks evaluating size and time discrimination capacities Blood sampling for the determination of plasma endocannabinoids levels
|
Computer-based tasks designed to assess size and time discrimination capacities
Blood drawn for the measurement of circulating endocannabinoids concentrations
|
Experimental: Normal-weight healthy volunteers
Computer-based tasks evaluating size and time discrimination capacities Blood sampling for the determination of plasma endocannabinoids levels
|
Computer-based tasks designed to assess size and time discrimination capacities
Blood drawn for the measurement of circulating endocannabinoids concentrations
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in the Point of subjective equality (PSE)
Periodo de tiempo: From fasting to satiety conditions 3 days apart (days 4 and 7 after inclusion)
|
The PSE is defined as the ratio "F"/"D" or "C"/"D" for which the stimulus "F" or "C" was judged greater than "D" with a probability of 0.5
|
From fasting to satiety conditions 3 days apart (days 4 and 7 after inclusion)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in the Percentage of subjective discrimination (PSD)
Periodo de tiempo: From fasting to satiety conditions 3 days apart (days 4 and 7 after inclusion)
|
The PSD is defined as the percentage of responses where the stimulus "F" or "C" was judged greater than "D" during the trials where the stimulus "F" or "C" was physically equal to "D", in terms of size or duration of presentation.
|
From fasting to satiety conditions 3 days apart (days 4 and 7 after inclusion)
|
Circulating endocannabinoids concentrations
Periodo de tiempo: Determined on blood samples collected during the experimental sessions under fasting and satiety (days 4 and 7 after inclusion)
|
Determined on blood samples collected during the experimental sessions under fasting and satiety (days 4 and 7 after inclusion)
|
Colaboradores e Investigadores
Investigadores
- Investigador principal: Bruno Aouizerate, Professor, Neurocentre Magendie (INSERM U862)
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- C13-33
- 2013-A00982-43 (Identificador de registro: IDRCB)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Computer-based tasks
-
Mackay Medical CollegeTerminadoProblema de salud mentalTaiwán
-
Heidelberg UniversityDesconocidoRetraso de idioma | Trastornos del desarrollo del lenguajeAlemania
-
University Hospital, BordeauxTerminadoEnfermedad de ParkinsonFrancia
-
University College, LondonDesconocidoEstilo de vida sedentario | Apetito y Trastornos Generales de la NutriciónReino Unido
-
Universidade da MadeiraServiço de Saúde da Região Autónoma da Madeira (SESARAM), E.P.E.Reclutamiento
-
Universidad Francisco de VitoriaHospital Beata María AnaTerminado
-
Universidad de GranadaChair in Conscience and Development (UGR); Mind, Brain and Behaviour Research...TerminadoAnsiedad | Trastorno sicologico | Perfeccionismo | Atención | Empatía | Creatividad | Estrés de la vida | Inteligencia emocionalEspaña